Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspectives in Medicinal Chemistry

Nitrogen-containing Heterocycle: A Privileged Scaffold for Marketed Drugs

Author(s): Feng Wang, Yongfang Yao, Hai-liang Zhu* and Yinghui Zhang*

Volume 21, Issue 6, 2021

Published on: 04 March, 2021

Page: [439 - 441] Pages: 3

DOI: 10.2174/156802662106210304105631

Next »
[1]
Sobarzo-Sanchez, E. Editorial (Thematic Issue: Heterocycle and hydrocarbon compounds from natural sources in medicinal chemistry: From synthesis to computational design in pharmacological applications - Part II). Curr. Top. Med. Chem., 2017, 17(4), 381-382.
[http://dx.doi.org/10.2174/1568026616666160906142336] [PMID: 28117015]
[2]
Chhabria, M.T.; Patel, S.; Modi, P.; Brahmkshatriya, P.S. Thiazole: a review on chemistry, synthesis and therapeutic importance of its derivatives. Curr. Top. Med. Chem., 2016, 16(26), 2841-2862.
[http://dx.doi.org/10.2174/1568026616666160506130731] [PMID: 27150376]
[3]
Pennington, L.D.; Moustakas, D.T. The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization. J. Med. Chem., 2017, 60(9), 3552-3579.
[http://dx.doi.org/10.1021/acs.jmedchem.6b01807] [PMID: 28177632]
[4]
Duan, Y.; Liu, W.; Tian, L.; Mao, Y.; Song, C. Targeting tubulin-colchicine site for cancer therapy: inhibitors, antibody- drug conjugates and degradation agents. Curr. Top. Med. Chem., 2019, 19(15), 1289-1304.
[http://dx.doi.org/10.2174/1568026619666190618130008] [PMID: 31210108]
[5]
Wang, Y.; Yao, Y.; Zhu, H.L.; Duan, Y. Butterfly structure: a privileged scaffold targeting tubulin-colchicine binding site. Curr. Top. Med. Chem., 2020, 20(17), 1505-1508.
[http://dx.doi.org/10.2174/1568026620999200616132924] [PMID: 32543362]
[6]
Duan, Y-T.; Sangani, C.B.; Liu, W.; Soni, K.V.; Yao, Y. New promises to cure cancer and other genetic diseases/disorders: epi-drugs through epigenetics. Curr. Top. Med. Chem., 2019, 19(12), 972-994.
[http://dx.doi.org/10.2174/1568026619666190603094439] [PMID: 31161992]
[7]
Xia, L-W.; Ba, M-Y.; Liu, W.; Cheng, W.; Hu, C-P.; Zhao, Q.; Yao, Y-F.; Sun, M-R.; Duan, Y-T. Triazol: a privileged scaffold for proteolysis targeting chimeras. Future Med. Chem., 2019, 11(22), 2919-2973.
[http://dx.doi.org/10.4155/fmc-2019-0159] [PMID: 31702389]
[8]
Liu, W.; Wang, X.; Zhu, H.; Duan, Y. Precision tumor medicine and drug targets. Curr. Top. Med. Chem., 2019, 19(17), 1488-1489.
[http://dx.doi.org/10.2174/156802661917190828111130] [PMID: 31592750]
[9]
Duan, Y.; Zhu, H. The advance in important target proteins. Curr. Top. Med. Chem., 2019, 19(15), 1275-1275.
[http://dx.doi.org/10.2174/156802661915190827162456] [PMID: 31526338]
[10]
Vitaku, E.; Smith, D.T.; Njardarson, J.T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem., 2014, 57(24), 10257-10274.
[http://dx.doi.org/10.1021/jm501100b] [PMID: 25255204]

Rights & Permissions Print Cite
Article Metrics
15
1
© 2024 Bentham Science Publishers | Privacy Policy